A Metabolomic Strategy to Screen the Prototype Components and Metabolites of Shuang-Huang-Lian Injection in Human Serum by Ultra Performance Liquid Chromatography Coupled with Quadrupole Time-of-Flight Mass Spectrometry
Figure 5
The trend plot of 7.41-285.0762 in positive mode between C group (■) and SHLI group (▲).